Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer
Clinical trial NCT03589950 · UNKNOWN
Trial details
- NCT number
- NCT03589950
- Sponsor
- The First People's Hospital of Lianyungang
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2020-08-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.